Adrenergic regulation of vascular smooth muscle tone in calf digital artery

Authors: C. Belloli1; P. Badino2; F. Arioli3; R. Odore2; G. Re2

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 27, Number 4, August 2004 , pp. 247-254(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Belloli, C., Badino, P., Arioli, F., Odore, R., Re, G. Adrenergic regulation of vascular smooth muscle tone in calf digital artery. J. vet. Pharmacol. Therap.27, 247–254.

Radioligand binding studies and functional assays on isolated smooth muscle preparations were performed in order to obtain a biochemical and functional characterization of the bgr-adrenoceptor (bgr-AR) subtypes involved in regulation of the smooth muscle relaxation of the calf's common digital artery. The results indicate that the common digital artery possesses two bgr-AR populations (40%bgr1 and 60%bgr2) and the bgr2-subtype appears to predominate as far as function is concerned. Only the bgr2-AR agonists clenbuterol and fenoterol caused dose-related relaxant effects, antagonized by propranolol, when tested in preparations precontracted both with PGF2agr (1.4 × 10-5 m) and noradrenaline (1.2 × 10-6 m). In noradrenaline precontracted preparations the bgr1-AR selective agonists dobutamine and xamoterol caused vasodilation which was not antagonized by (±)propranolol. While the functional relaxant effects of dobutamine may be attributed to its potent competitive agr-AR blocking activity, further investigations are required to explain the effect of xamoterol. The vasodilator effect of (±)isoproterenol was irregular. The recorded contractile effects, mainly at dosages greater than 10-6 m, suggest the loss of drug selectivity for bgr-AR and agr-AR activation. Indirect evidence indicates that the agr-adrenoceptor (agr-AR) population in this tissue which produces a strong contraction is functionally dominant over the bgr-AR, suggesting limited therapeutic benefit for bgr-AR drugs to control blood flow disorders in the calf's distal limb.

Document Type: Research article

DOI: 10.1111/j.1365-2885.2004.00588.x

Affiliations: 1: Department of Animal Health and Welfare, Division of Veterinary Pharmacology and Toxicology, University of Bari, Valenzano, Italy; 2: Department of Animal Pathology, Division of Veterinary Pharmacology and Toxicology, University of Turin, Grugliasco, Turin, Italy; 3: Department of Veterinary Sciences and Technologies for Food Safety, University of Milan, Milan, Italy

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A